Tuesday, 20 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

CARPINIENNE PART. Stock Drops By 25% In The Last 10 Sessions

Loading stream...

(vianews) - shares of carpinienne part. (cac 40: carp.pa) dropped by a staggering 25.16% in 10 sessions from 7.75 € to 5.80 € at 19:55 est on wednesday, after five successive sessions in a row of losses. cac 40 is dropping 0.18% to 7,119.83 €, after two consecutive sessions in a row of losses.

about carpinienne part.

carpinienne de participations operates as an investment company. it holds 5.14% interests in foncière euris, which has a property portfolio that primarily consists of shopping malls. the company was founded in 1968 and is headquartered in paris, france. carpinienne de participations is a subsidiary of finatis société anonyme.

earnings per share

as for profitability, carpinienne part. has a trailing twelve months eps of -1.34 €.

more news about carpinienne part. (carp.pa).

Categories

stockMarket

Tags

CARPINIENNE PART.Stock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockCARP.PA
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com